Location History:
- Monza, IT (1998 - 2001)
- Milan, IT (2001)
Company Filing History:
1 out of 25 
1 out of 480 
1 out of 6 Years Active: 1998-2001
Title: Marco Conti - Innovator in Antitumor Agents
Introduction
Marco Conti is a distinguished inventor based in Monza, Italy, recognized for his contributions to the field of pharmaceutical innovations. With a total of three patents to his name, Conti has focused primarily on developing compounds with significant antitumor activities, showcasing his commitment to advancing medical science.
Latest Patents
Among Marco Conti's most recent inventions are two noteworthy patents that illustrate his innovative approach to cancer treatment. The first patent involves ureido and thioureido derivatives of 4-amino-2(5H)-furanones and 4-amino-2(5H)-thiophenones, which are designed to serve as antitumor agents. This invention presents a promising avenue for tumor treatment through novel chemical structures.
The second patent details the development of bis-phosphonate conjugates with alkylating moieties that exhibit antitumor activity. This invention relates to conjugates of 3-carboxy-4,4′-dihydroxyphosphorylbutenoic acids combined with alkylating agents, which have demonstrated substantial activity against multiple myeloma. Additionally, it includes a process for their preparation and the pharmaceutical compositions that incorporate these innovative compounds.
Career Highlights
Marco Conti has built a notable career through his work in leading pharmaceutical companies. He has contributed significantly to research and development efforts at Boehringer Mannheim Italia and Roche Diagnostics, where his expertise has facilitated advancements in drug development.
Collaborations
Throughout his career, Marco has collaborated with esteemed colleagues, including Ernesto Menta and Silvano Spinelli. These collaborations have enriched his work and have been instrumental in the progress of various projects aimed at providing innovative solutions in the pharmaceutical industry.
Conclusion
In conclusion, Marco Conti stands out as a prominent figure in the field of pharmaceutical inventions, especially in the realm of antitumor agents. His patents reflect a deep commitment to finding new and effective treatments for cancer, and his collaborations with notable professionals further enhance his influence in the industry. As he continues to innovate, Marco Conti's contributions are poised to make a lasting impact on healthcare and cancer treatment.